Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2025-12-25 @ 9:15 PM
NCT ID: NCT00748956
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT00748956
Study Brief: Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Low Dose NPY Low dose, Receive 50 nmol dose of NPY Low dose NPY: 50nmol, administered intranasally 0 None 0 0 0 0 View
High Dose NPY High Dose, Receive 100 nmol dose of NPY High dose NPY: 100nmol administered intranasally 0 None 1 5 0 5 View
Placebo Placebo comparator Placebo: placebo comparator (0nmol)) administered intranasally 0 None 1 5 0 5 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Headache and Nausea None Nervous system disorders None View
Headache None Nervous system disorders None View
Other Events(If Any):